Comparison of immunological and endocrinological markers associated with major depression

Journal of International Medical Research

Volumn 31, Issue 1, 2003, Pages 36-41

  Jozuka, H ^a   Jozuka, E ^a   Takeuchi, S ^b   Nishikaze, O ^c  

^a JMC Stress Medical Institute   (Japan)

^b Handa Med Hlth Admin Centre   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cortisol; Dehydroepiandrosterone; Interleukin 2; Major depression; Natural killer cell activity

Indexed keywords

FLUOXETINE; HYDROCORTISONE; INTERLEUKIN 2; NORFLUOXETINE; PAROXETINE; PRASTERONE; PRASTERONE SULFATE;

ADULT; ARTICLE; CHROMIUM 51 RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR DEPRESSION; MALE; NATURAL KILLER CELL; PROTEIN BLOOD LEVEL; RATING SCALE; SCORING SYSTEM;

EID: 0037224125     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000303100106     Document Type: Article

References (37)

1. Jozuka H: Panic attacks and serum IgE levels in depressive states (in Japanese). Seishin-Igaku 1988; 25: 87 - 91.
2. Jozuka H: T lymphocyte subsets in major depressions (in Japanese). Teishin-Igaku 1988; 40: 477 - 482.
3. Jozuka H: T lymphocyte subsets in panic disorders (in Japanese). Seishin-Igaku 1989; 31: 1336 - 1340.
4. Jozuka H: Immunological studies in anxiety and depressive states (in Japanese). Teishin-Igaku 1990; 42: 599 - 605.
5. Jozuka H: Endogenous psychiatric disorders and immune responses (in Japanese). IMAGO (Seidosha, Tokyo) 1993; 12: 122 - 131.
6. Masek K, Petrovicky P, Sevcik J, Zidek Z, Frankova D: Past, present and future of psychoneuroimmunology. Toxicology 2000, 142: 179 - 188.
7. Webster JI, Tonelli L, Sternberg EM: Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20: 125 - 163.
8. Raison CL, Miller AH: The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry 2001; 6: 277 - 294.
9. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, et al: Indicators of immune activation in major depression. Psychiatry Res 1996; 64: 161 - 167.
10. Sluzewska A: Indicators of immune activation in depressed patients. Adv Exp Med Biol 1999; 461: 59 - 73.
11. Irwin M: Immune correlates of depression. Adv Exp Med Biol 1999; 461: 1 - 24.
12. Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J: Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 1990-1991; 24: 115 - 120.
13. Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, et al. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induces depressive and anxiety symptoms and immune activation. Mol Psychiatry 2001; 6: 475 - 480.
14. van West D, Maes M: Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuroendocrinol Lett 1999; 20: 11 - 17.
15. Nishikaze O: Stress and adaptation in humans-aging, illness, psychosocial stress (in Japanese). Rinsho Byori 1994; 42: 321 - 330.
16. Nishikaze O, Furuya E: Stress and anticortisols-17-ketosteroid sulfate conjugate as a biomarker in tissue repair and recovery (in Japanese). J UOEH 1998; 20: 273 - 295.
17. Jozuka H (ed): Psychoneuroimmunopathology. Nagoya: Marusen, 2000.
18. Goodyer IM, Herbert J, Altham PM, Pearson J, Secher SM, Shiers HM: Adrenal secretion during major depression in 8- to 16-year-olds. I. Altered diurnal rhythms in salivary cortison and dehydroepiandrosterone (DHEA) at presentation. Psychol Med 1996; 26: 245 - 256.
19. Cruse JM, Lewis RE (eds): Atlas of Immunology. New York: CRC Press, 1998; pp23 - 58, 185 - 206.
20. Osumi K: Natural killer cell activity test (in Japanese). Rinsho Byori 1981; 45 (Suppl): 299 - 309.
21. Baulieu EE (ed): Neurosteroids. Totowa: Humana Press, 1990.
22. Zung WW, Richards CB, Short MJ: Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508 - 515.
23. Caldwell CL, Irwin M, Lohr J: Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol Psychiatry 1991; 30: 1131 - 1138.
24. Irwin M, Lacher U, Caldwell CL: Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol Med 1992; 22: 1045-1050.
25. Mohl PC, Huang L, Bowden C, Fischbach M, Vogtsberger K, Talal N: Natural killer cell activity in major depression. Am J Psychiatry 1987; 144: 1619.
26. Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, et al: Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. J Immunol 1985; 134: 1503 - 1507.
27. Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H: Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry 1994; 35: 42 - 47.
28. Carson WE, Yu H, Dierksheide J, Pfeffer K, Bouchard P, Clark R, et al: A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 1999; 162: 4943 - 4951.
29. Maes M, Capuron L, Ravaud A, Gualde N, Bosmans E, Egyed B, et al: Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology 2001; 24: 130 - 140.
30. Kathol RG: Circannual rhythm and peak frequency of corticosteroid excretion: relationship to affective disorder. Psychiatr Med 1985; 3: 53 - 63.
31. Herman JP, Watson SJ: Stress regulation of mineralocorticoid receptor heteronuclear RNA in rat hippocampus. Brain Res 1995; 677: 243 - 249.
32. Miller AH, Asnis GM, Lackner C, Halbreich U, Norin AJ: Depression, natural killer cell activity, and cortisol secretion. Biol Psychiatry 1991; 29: 878 - 886.
33. Loria RM, Padgett DA, Huynh PN: Regulation of the immune response by dehydroepiandrosterone and its metabolites. J Endocrinol 1996; 150: S209 - S220.
34. Furuya E, Maezawa M, Nishikaze O: 17-KS sulfate as a biomarker in psychosocial stress (in Japanese). Rinsho Byori 1998; 46: 529 - 537.
35. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, et al: Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997; 41: 311 - 318.
36. Frank MG, Hendricks SE, Johnson DR, Wieseler JL, Burke WJ: Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 1999; 39: 18 - 24.
37. Helgason CM, Frank JL, Johnson DR, Frank MG, Hendricks SE: The effects of St John's Wort (Hypericum perforatum) on NK cell activity in vitro. Immunopharmacology 2000; 46: 247 - 251.